International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12395 - 12395
Published: Nov. 19, 2024
Irritable
bowel
syndrome
(IBS)
is
one
of
the
most
prevalent
functional
gastrointestinal
disorders
characterized
by
recurrent
abdominal
pain
and
altered
habits.
The
exact
pathophysiological
mechanisms
for
IBS
development
are
not
completely
understood.
Several
factors,
including
genetic
predisposition,
environmental
psychological
influences,
low-grade
inflammation,
alterations
in
motility,
dietary
habits,
have
been
implicated
pathophysiology
disorder.
Additionally,
emerging
evidence
highlights
role
gut
microbiota
IBS.
This
review
aims
to
thoroughly
investigate
how
impact
physiological
functions
such
as
brain-gut
axis,
immune
system
activation,
mucosal
permeability,
intestinal
motility.
Our
research
focuses
on
dynamic
"microbiome
shifts",
emphasizing
enrichment
or
depletion
specific
bacterial
taxa
their
profound
disease
progression
pathology.
data
indicated
that
populations
IBS,
reductions
beneficial
species
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(23), P. 5140 - 5140
Published: Dec. 2, 2022
Inflammatory
bowel
disease
(IBD),
comprising
Crohn's
(CD)
and
ulcerative
colitis
(UC),
is
characterized
as
a
chronic
recurrent
inflammatory
whose
pathogenesis
still
elusive.
The
gut
microbiota
exerts
important
diverse
effects
on
host
physiology
through
maintaining
immune
balance
generating
health-benefiting
metabolites.
Many
studies
have
demonstrated
that
IBD
associated
with
disturbances
in
the
composition
function
of
microbiota.
Both
abundance
diversity
are
dramatically
decreased
patients.
Furthermore,
some
particular
classes
microbiota-derived
metabolites,
principally
short-chain
fatty
acids,
tryptophan,
its
bile
acids
also
been
implicated
IBD.
In
this
review,
we
aim
to
define
disturbance
key
metabolites
pathogenesis.
addition,
focus
scientific
evidence
probiotics,
not
only
molecular
mechanisms
underlying
beneficial
probiotics
but
challenges
it
faces
safe
appropriate
application.
Frontiers in Physiology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 8, 2024
The
intestinal
wall
is
a
selectively
permeable
barrier
between
the
content
of
lumen
and
internal
environment
body.
Disturbances
permeability
can
potentially
lead
to
unwanted
activation
enteric
immune
system
due
excessive
contact
with
gut
microbiota
its
components,
development
endotoxemia,
when
level
bacterial
lipopolysaccharides
increases
in
blood,
causing
chronic
low-intensity
inflammation.
In
this
review,
following
aspects
are
covered:
structure
barrier;
influence
on
via
regulation
functioning
tight
junction
proteins,
synthesis/degradation
mucus
antioxidant
effects;
molecular
mechanisms
pro-inflammatory
response
caused
by
invasion
through
TLR4-induced
TIRAP/MyD88
TRAM/TRIF
signaling
cascades;
nutrition
permeability,
exercise
an
emphasis
exercise-induced
heat
stress
hypoxia.
Overall,
review
provides
some
insight
into
how
prevent
associated
inflammatory
processes
involved
many
if
not
most
pathologies.
Some
diets
physical
supposed
be
non-pharmacological
approaches
maintain
integrity
function
provide
efficient
operation.
However,
at
early
age,
increased
has
hormetic
effect
contributes
system.
World Journal of Gastroenterology,
Journal Year:
2023,
Volume and Issue:
29(1), P. 19 - 42
Published: Jan. 3, 2023
The
gut
microbiota
is
currently
considered
an
external
organ
of
the
human
body
that
provides
important
mechanisms
metabolic
regulation
and
protection.
encodes
over
3
million
genes,
which
approximately
150
times
more
than
total
number
genes
present
in
genome.
Changes
qualitative
quantitative
composition
microbiome
lead
to
disruption
synthesis
key
bacterial
metabolites,
changes
intestinal
barrier
function,
inflammation
can
cause
development
a
wide
variety
diseases,
such
as
diabetes,
obesity,
gastrointestinal
disorders,
cardiovascular
issues,
neurological
disorders
oncological
concerns.
In
this
review,
I
consider
issues
related
role
its
influence
on
physiological
pathological
processes
occurring
body,
potential
new
therapeutic
strategies
aimed
at
restoring
microbiome.
Herewith,
it
understand
should
be
single
biological
system,
where
change
one
element
will
inevitably
affect
other
components.
Thus,
study
impact
health
only
taking
into
account
numerous
factors,
has
not
yet
been
fully
elucidated.
Fertility and Sterility,
Journal Year:
2023,
Volume and Issue:
120(3), P. 682 - 694
Published: May 12, 2023
To
explore
the
role
of
gut
dysbiosis-derived
β-glucuronidase
(GUSB)
in
development
endometriosis
(EMs).16S
rRNA
sequencing
stool
samples
from
women
with
(n
=
35)
or
without
30)
and
a
mouse
model
was
conducted
to
assess
microbiome
changes
identify
molecular
factors
influencing
endometriosis.
Experiments
vivo
an
C57BL6
vitro
verified
level
GUSB
its
EMs.Department
Obstetrics
Gynecology,
The
First
Affiliated
Hospital
Sun
Yat-sen
University;
Guangdong
Provincial
Clinical
Research
Center
for
Obstetrical
Gynecological
Diseases.Women
reproductive
age
histological
diagnosis
were
enrolled
group
infertile
healthy
age-matched
who
had
undergone
gynecological
radiological
examination
control
30).
Fecal
blood
taken
day
before
surgery.
Paraffin-embedded
sections
50
bowel
endometriotic
lesions,
uterosacral
normal
endometria
collected.None.Changes
patients
EMs
mice
effect
on
proliferation
invasion
endometrial
stromal
cells
lesions
assessed.No
difference
α
β
diversity
found
between
controls.
Immunohistochemistry
analysis
showed
higher
expression
ligament
than
endometrium
(p<0.01).
β-Glucuronidase
promoted
migration
during
cell
counting
kit-8,
Transwell,
wound-healing
assays.
Macrophage
levels,
especially
M2,
controls,
M0
M2
transition.
Medium
conditioned
by
β-glucuronidase-treated
macrophages
migration.
increased
number
volume
present
model.This
directly
indirectly
causing
macrophage
dysfunction.
characterization
pathogenic
has
potential
therapeutic
implications.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Feb. 16, 2024
Endometriosis
(EMs)
is
a
prevalent
gynecological
disorder
characterized
by
the
growth
of
uterine
tissue
outside
cavity,
causing
debilitating
symptoms
and
infertility.
Despite
its
prevalence,
exact
mechanisms
behind
EMs
development
remain
incompletely
understood.
This
article
presents
comprehensive
overview
relationship
between
gut
microbiota
imbalance
pathogenesis.
Recent
research
indicates
that
plays
pivotal
role
in
various
aspects
EMs,
including
immune
regulation,
generation
inflammatory
factors,
angiopoietin
release,
hormonal
endotoxin
production.
Dysbiosis
can
disrupt
responses,
leading
to
inflammation
impaired
clearance
endometrial
fragments,
resulting
endometriotic
lesions.
The
dysregulated
contribute
release
lipopolysaccharide
(LPS),
triggering
chronic
promoting
ectopic
adhesion,
invasion,
angiogenesis.
Furthermore,
involvement
estrogen
metabolism
affects
levels,
which
are
directly
related
development.
review
also
highlights
potential
as
diagnostic
tool
therapeutic
target
for
EMs.
Interventions
such
fecal
transplantation
(FMT)
use
preparations
have
demonstrated
promising
effects
reducing
symptoms.
progress
made,
further
needed
unravel
intricate
interactions
paving
way
more
effective
prevention
treatment
strategies
this
challenging
condition.
The Prostate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 14, 2024
Abstract
Background
Gut
microbiome
is
a
community
of
microorganisms
that
lives
in
the
human
intestine
and
exerts
various
functions
on
host,
including
metabolic,
immunoregulatory,
control
over
cell
proliferation.
alterations
have
been
associated
with
pathological
conditions,
such
as
diabetes
mellitus,
obesity,
cardiovascular
diseases.
Gut‐prostate
axis
explained
by
association
between
gut
quantitative
functional
along
increased
intestinal
epithelial
permeability
prostatediseases.
However,
pathophysiological
mechanisms
clinical
importance
this
are
not
completely
clarified
yet.
Methods
We
conducted
narrative
review
most
relevant
articles
Medline
(US
National
Library
Medicine,
Bethesda,
MD,
USA),
Scopus
(Elsevier,
Amsterdam,
The
Netherlands)
Web
Science
Core
Collection
(Thomson
Reuters,
Toronto,
ON,
Canada)
databases.
No
chronological
restrictions
were
applied,
related
papers
published
until
December
2023
included.
Results
microbiota
(GM)
its
metabolites
capable
modifying
host
androgen
level,
well
prostate
cancer
(PCa)
therapy
response.
Moreover,
patients
inflammatory
bowel
disease
higher
rates
prostatitis‐like
symptoms
potential
risk
developing
PCa.
Conclusions
There
evidence
interventions
GM
high
to
serve
diagnostic
therapeutic
tools
for
diseases,